| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |